Skip to main content
. 2017 Apr 4;35(15):1898–1906. doi: 10.1016/j.vaccine.2017.02.038

Fig. 3.

Fig. 3

ELISpot response for two malaria peptide pools against arbitrary cutoff for positive response. Loss of response magnitude can reduce rates of positivity based on pre-determined cutoff if overall immunogenicity of a specific peptide is weak. Reduction in responder frequency was greatest where the overall immunogenicity was highest at the peak time point after MVA boosting.